These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 17128432)
1. Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum. Sachin BS; Sharma SC; Sethi S; Tasduq SA; Tikoo MK; Tikoo AK; Satti NK; Gupta BD; Suri KA; Johri RK; Qazi GN Phytother Res; 2007 Feb; 21(2):157-63. PubMed ID: 17128432 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction of some antitubercular drugs with caraway: implications in the enhancement of drug bioavailability. Sachin BS; Monica P; Sharma SC; Satti NK; Tikoo MK; Tikoo AK; Suri KA; Gupta BD; Johri RK Hum Exp Toxicol; 2009 Apr; 28(4):175-84. PubMed ID: 19734267 [TBL] [Abstract][Full Text] [Related]
3. Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market. Pillai G; Fourie PB; Padayatchi N; Onyebujoh PC; McIlleron H; Smith PJ; Gabriels G Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S309-16; discussion S317-21. PubMed ID: 10593710 [TBL] [Abstract][Full Text] [Related]
4. Cuminum cyminum extract attenuates scopolamine-induced memory loss and stress-induced urinary biochemical changes in rats: a noninvasive biochemical approach. Koppula S; Choi DK Pharm Biol; 2011 Jul; 49(7):702-8. PubMed ID: 21639683 [TBL] [Abstract][Full Text] [Related]
5. Flavonoid glucosides from the hairy roots of Catharanthus roseus. Chung IM; Ahmad A; Ali M; Lee OK; Kim MY; Kim JH; Yoon DY; Peebles CA; San KY J Nat Prod; 2009 Apr; 72(4):613-20. PubMed ID: 19271765 [TBL] [Abstract][Full Text] [Related]
6. The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailability. McIlleron H; Gabriels G; Smith PJ; Fourie PB; Ellard GA Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S329-35; discussion S351-2. PubMed ID: 10593713 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability of rifampicin in a separate formulation and fixed dose combination with isoniazid NIH: a case for a fixed dose combination (FDC) for the treatment of tuberculosis. Nyazema NZ; Rabvukwa P; Gumbo J; Ndudzo P; Chitemerere C Cent Afr J Med; 1999 Jun; 45(6):141-4. PubMed ID: 10695183 [TBL] [Abstract][Full Text] [Related]
9. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety. Singh H; Jindal S; Singh M; Sharma G; Kaur IP Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294 [TBL] [Abstract][Full Text] [Related]
10. Effect of subinhibitory concentrations of cumin (Cuminum cyminum L.) seed essential oil and alcoholic extract on the morphology, capsule expression and urease activity of Klebsiella pneumoniae. Derakhshan S; Sattari M; Bigdeli M Int J Antimicrob Agents; 2008 Nov; 32(5):432-6. PubMed ID: 18715764 [TBL] [Abstract][Full Text] [Related]
11. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms. Agrawal S; Panchagnula R Biopharm Drug Dispos; 2005 Nov; 26(8):321-34. PubMed ID: 16059874 [TBL] [Abstract][Full Text] [Related]
12. Influence of Moringa oleifera on pharmacokinetic disposition of rifampicin using HPLC-PDA method: a pre-clinical study. Pal A; Bawankule DU; Darokar MP; Gupta SC; Arya JS; Shanker K; Gupta MM; Yadav NP; Singh Khanuja SP Biomed Chromatogr; 2011 Jun; 25(6):641-5. PubMed ID: 20845375 [TBL] [Abstract][Full Text] [Related]
13. The evaluation of rifampicin bioavailabilities of fixed-dose combinations of anti-tuberculosis drugs: procedures for ensuring laboratory proficiency. Ellard GA Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S322-4; discussion S351-2. PubMed ID: 10593711 [TBL] [Abstract][Full Text] [Related]